We also established a nomogram based on several clinical factors (gender, race, first event, disease at diagnosis, and PDE1B gene expression) to further forecast the 1-, 3-, 5-year OS probabilities of osteosarcoma patients intuitively with good performance. This evidence concerns the gene PDE1B and osteosarcoma.